OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 69 filers reported holding OCULAR THERAPEUTIX INC in Q4 2017. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $70,635 | -1.9% | 13,689 | -20.8% | 0.00% | – |
Q3 2022 | $72,000 | -51.4% | 17,291 | -53.1% | 0.00% | -100.0% |
Q2 2022 | $148,000 | -25.6% | 36,891 | +85.3% | 0.00% | 0.0% |
Q3 2021 | $199,000 | -59.6% | 19,913 | -42.6% | 0.00% | -50.0% |
Q2 2021 | $492,000 | +49.5% | 34,681 | +73.2% | 0.00% | 0.0% |
Q1 2021 | $329,000 | +53.7% | 20,026 | +94.1% | 0.00% | 0.0% |
Q4 2020 | $214,000 | -75.9% | 10,315 | -91.2% | 0.00% | -83.3% |
Q3 2020 | $889,000 | -28.5% | 116,846 | -21.7% | 0.01% | -40.0% |
Q2 2020 | $1,243,000 | +886.5% | 149,257 | +487.1% | 0.02% | +566.7% |
Q1 2020 | $126,000 | +186.4% | 25,424 | +77.2% | 0.00% | – |
Q3 2019 | $44,000 | -55.6% | 14,348 | -35.5% | 0.00% | -100.0% |
Q4 2017 | $99,000 | -32.2% | 22,243 | +41.6% | 0.00% | -33.3% |
Q2 2017 | $146,000 | -71.4% | 15,703 | -74.3% | 0.00% | -85.7% |
Q4 2016 | $510,000 | – | 60,985 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
Covestor Ltd | 37,404 | $117 | 0.09% |
GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |